Clinical Trial

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Name: Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones — clinical trial record (NCT06003348)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2023-08-14; most recent amendment 2026-06-01.

Status change: Not Yet Recruiting → Recruiting 2023-10-11

Trial Details

NCT Number	NCT06003348
Lead Sponsor	University of Texas Southwestern Medical Center
Conditions	Calcium Phosphate Kidney Stones
Enrollment	25 participants
Start Date	2023-12-13
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-02